Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: A systematic review and meta-analysis.
Yaghoobpoor S, Fathi M, Vakili K, Sayehmiri F, Alipour M, Miriran ZS, Ghayyem H, Tutunchian Z, Hajibeygi R, Batool Z, Mirzadeh M, Aghazadeh MH, Hajiesmaeili M.
Yaghoobpoor S, et al.
PLoS One. 2024 Apr 17;19(4):e0297091. doi: 10.1371/journal.pone.0297091. eCollection 2024.
PLoS One. 2024.
PMID: 38630771
Free PMC article.
We found that blood levels of IGF-1 (SMD = 0.20, 95% CI = -0.20 to 0.59, I2 = 82.4%, K = 8, n = 692), CSF level of IGF-1 (SMD = 0.25, 95% CI = -0.06 to 0.56, I2 = 0.0%, K = 3 n = 164) and blood levels of GH were not significantly higher in MS patients than controls …
We found that blood levels of IGF-1 (SMD = 0.20, 95% CI = -0.20 to 0.59, I2 = 82.4%, K = 8, n = 692), CSF level of IGF-1 (SMD = 0.25, …